This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
LONDON (Reuters) - The dollar edged higher to a new nine-day high on Thursday thanks to a bounce in equities and concerns that U.S. inflation pressures will pick up, although worries about an escalation in trade conflict capped gains.
MS.PRI MS.PRK MS.PRE ACA MS.PRF MS.PRG MS CRARY MS.PRA CRARF
LONDON, July 9 — The Chinese yuan rebounded and the euro rose to its highest since June 14 today as investors bought riskier assets following favourable US jobs data last week and evidence that global trade tension has not yet slowed economic momentum.
ACA CRARY CRARF
June 29 - Financial Times (Peter Wells): "The buck is back. Tighter domestic monetary policy and global trade turmoil have set the US dollar for its best quarterly performance since December 2016. The DXY index, which tracks the US currency against a weighted basket of global peers, was up 5.2% in the three months to June 29. That has been achieved via a three-month winning streak, its first such run since December 2016, too.
BBDO CHKVP UAA MS.PRE MS.PRF MS.PRG CHKVZ MS.PRA SCGLF TWTR MS CHK.PRD CICHF CCB SCGLY TYT BDORY CMG BBD VLKAF NDAQ MS.PRI CHK MS.PRK 7203 SFUN GLE FB DB TIF HES TM NFLX AMD CBQS CHKDH CHKDG FMCKI FMCKJ CHKDJ KR ESV CHKDP ACA 0939 CKRGZ FMCCO FMCCP HYUO FMCCM FMCCN 55BC TRIP FMCCI ITUB FMCCJ M FMCCG FMCKO NYTAB FMCKP FMCKM CRARF TOYOF FMCKN FMCKK HYUD FMCKL CHKWZ DO CICHY UA ING OAS FMCC CHK.WI TSLA HYUP CRARY FMCCS FMCCT
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ACA CRARY CRARF
Some of the world’s largest money managers soured on emerging markets as compounding trade threats deepened the worst monthly rout for developing currencies since the U.S. election.
C.WSA GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS C.WS.B GLSSP CRZBF C.WS.A C.PRP ACA C.PRU MS MSCI C.PRS CRZBY JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG CRARF GSJ C.PRC GS.PRJ GS.PRI ASHM MS.PRI C.PRPCL GS.PRD MS.PRK CGBBW GS.PRC CRARY GJS GS.PRN GS.PRK
As part of its strategy to exit non-core operations across the globe, JPMorgan’s (JPM - Free Report) subsidiary, JPMorgan International Finance is selling its 7.5% stake back to Saudi Investment Bank for 759.3 million riyals ($203 million). The transaction, expected to close by September-end, is still subject to regulatory approvals. Notably, the Saudi bank will pay 13.5 riyals a share (a discount of nearly 24%) and plans to hold the shares as treasury stock, which will be re-issued as preferred shares later on.
HCS.PRB CRARF HCS HSB 0005 HFC HSEA ACA HSEB CRARY HSBC.PRA HSBC HBCYF
Major player: People walk inside JP Morgan headquarters in New York. JPMorgan is one the biggest foreign banks in Saudi Arabia and the only US lender with both investment and commercial banking licences. — Reuters
HSB HCS.PRB 0005 HSEA ACA HSEB CRARY HSBC.PRA CRARF HCS HSBC HBCYF
It wasn't a falling star Luis Caputo anticipated when he predicted just eight months ago that Argentina would prove the "star of emerging markets for the next 20 years."
WFCNP STAN DB WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO STAB WFC.PRN STAC SCBFF STAN ACA WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS CRARF 580001 2888 CRARY
The Bank of Japan left monetary policy unchanged Friday and downgraded its assessment of inflation, falling further behind its global peers at the end of a busy week for central banks.
ACA CRARY CRARF
BEIJING (June 8): China’s massive trade surplus with the world shrank in May. Unfortunately for the ongoing tensions with President Donald Trump, the surplus with the US didn’t.
ACA CRARY CRARF
Chicago, IL – June 5, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Zebra Technologies (ZBRA - Free Report) , Anhui Conch Cement (AHCHY - Free Report) and Graco (GGG - Free Report) .
WLH CCS DB AMC BNPQY WLK CTXS ASYS ZBRA BNPQF CRARF CDNS BNPZY WLS DK GGG MGA MG MLNX TTEK ACA MKSI 0914 CRARY
16h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
17h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to EPA:ACA / CREDIT AGRICOLE on message board site Silicon Investor.